 JPMorgan Chase Co. lifted its stake in shares of Enzo Biochem, Inc. NYSE:ENZ by 151.5 during the first quarter, according to its most recent filing with the Securities and Exchange Commission SEC. The institutional investor owned 65,293 shares of the medical research companys stock after purchasing an additional 39,331 shares during the quarter. JPMorgan ... 